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Inquiry into the Role of Skin Sulfhydryl Oxidase in Epidermal
Disul®de Bond Formation: Implications of the Localization
and Regulation of Skin SOx as Revealed by TPA, Retinoic
Acid, and UVB Radiation
To the Editor:
Our group has been engaged in clarifying the process of terminal
differentiation of keratinocytes, especially in post-translational
modi®cations such as isopeptide and disul®de cross-linking (S-S)
(Ogawa et al, 1979; Takamori et al, 1980). The newly formed S-S
bonds are thought to result in conformational changes in the
keratin bundles and corni®ed cell envelope (CCE) proteins, thus
presumably stabilizing the structure of keratinocytes in terminal
differentiation (Goldsmith, 1983). Ogawa et al (1979) have reported
conversion of free sulfhydryl groups (±SH) to S-S in human skin
using a ¯uorescent thiol reagent, N (7-dimethylamino-4-methyl
coumarinyl) maleimide (DACM) (Yamamoto et al, 1977), at the
junction of the living and corni®ed layers in the human epidermis.
We have isolated one of the enzymes that seems to be
responsible for S-S formation in rat skin and named it ``skin
sulfhydryl oxidase (skin SOx)'' (Takamori et al, 1980). Skin SOx
can introduce S-S bonds into a wide range of protein and peptide
substrates and our group also showed the conspicuous activity of
skin SOx at the junction of the corni®ed and living layers (Yamada,
1987), where the prominent conversion of free -SHs to S-S in the
keratinocyte occur in DACM staining.
From these results, it could be hypothesized that at least part of
the conversion from free -SHs to S-S in the skin is carried out by
skin SOx (Ogawa et al, 1979); however, there is no clear-cut
evidence that the S-S formation is overwhelmingly enzymatic,
because most of the S-S cross-links may result from spontaneous
oxidation or the other thiol enzyme catalysis (Haugaard, 1968;
Hashimoto et al, 2000). In response to this observation, we try to
show here that S-S and SOx are always distributed together in rat
epidermis even when the epidermis has been exposed to certain
chemical agents or has been subjected to UVB damage. We believe
that the data that we present will corroborate, if not prove, the idea
that skin sulfhydryl oxidase is responsible for disul®de bond
formation in rat epidermis.
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To identify the S-S bonds, free -SHs groups were blocked by
N-ethylmaleimide; then the S-S bonds were reduced by dithio-
threitol and labeled with DACM (Wako, Tokyo, Japan) (Ogawa et
al, 1979) (Fig 1i±l). Though DACM assay is sensitive and
quantitative enough to detect S-S histochemically, because of its
inherent instability, it has not yet been used successfully to clarify
the localization and expression of SOx clearly in the skin (Takamori
et al, 1980; Hashimoto et al, 2000); however, with our improved
method, we soaked biopsy specimens in a Bouin Hollande
Sublimate solution (10% saturated HgCl2 in 2.5% cupric acetate,
4% picric acid, 4% paraformaldehyde, and 1% acetic acid) at 4°C
overnight (Kumari et al, 1990) before cutting paraf®n sections for
the immunohistochemical studies. This step makes it possible to
demonstrate the expression and distribution of SOx very success-
fully in the skin section, using anti-SOx polyclonal antiserum
against rat-seminal vesicle enzyme as a primary antibody and
biotinated goat antirabbit IgG antibody (DAKO Japan, Tokyo,
Japan) as a secondary antibody. The sections were then incubated
with streptavidin-Cy3 conjugate (Sigma-Aldrich Japan, Tokyo,
Japan) (Fig 1e±h). Shown in Fig 1(e, arrowhead), skin SOx seemed
speci®cally to localize at the junction of the living and corni®ed
layers in rat epidermis. The positive layer cells seem to be in stratum
lucidum, which contains apoptotic nuclei (Fig 1a, e, arrows) in
normal rat skin. S-S bridges are apparent above the stratum lucidum
(Fig 1i), in other words, only in the periphery of cells in the whole
stratum corneum. No clear distribution of SOx or S-S was observed
in the lower epidermis and dermis.
Forty-eight hours after the local application of 100 ml 12-O-
tetradecanoyl-phorbol-13-acetate (TPA, 0.03% in acetone, Sigma),
conspicuous expression of SOx in the stratum lucidum was observed
(Fig 1f) with strong ¯uorescence of the whole stratum corneum
(Fig 1j) in the S-S staining. On the other hand, decreased staining
of skin SOx (Fig 1g) with faint S-S staining in the stratum corneum
(Fig 1k) was observed 48 h after the local application of 100 ml all-
trans-retinoic acid (RA, 0.01% in acetone, Sigma). These ®ndings
suggest that the SOx gene expression and S-S bond formation was
regulated by a TPA-responsive element and retinoid-signaling
pathway in the upper epidermis.
Recent studies demonstrate that the expression of CCE-related
proteins, such as involucrin and loricrin, as well as transglutaminase
(Takahashi, 1993), are upregulated by TPA treatment in the skin.
Reduction of gene expression by retinoids is also reported for the
differentiation-speci®c markers, such as keratins 1 and 10, loricrin,
and pro®laggrin (Darmon and Blumenberg, 1993) in the upper
epidermis. Because SOx is supposed to catalyze the reaction in
high-cysteine proteins (Takamori et al, 1980), precursor proteins
for CCE formation such as loricrin or involucrin might be a good
substrate.
After newborn rat skin was irradiated with ultraviolet B (2MED,
190 mJ per cm2), apoptotic sunburn cells (SBCs) appeared at 12 h
and reached a peak at 48 h as previously reported (Danno and
Horio, 1980). In the DACM assay for S-S bonds, ¯uorescence was
often observed in the cytoplasm of SBCs (Fig 1l, arrow) and
strongly, in the stratum corneum. Regarding SOx, this treatment
upregulated enzyme expression in the stratum lucidum (Fig 1h,
arrowhead). Moreover, abundant SOx expression was also evident
especially in the cytoplasm of SBCs in the stratum basale and
spinosum (Fig 1h, arrow). These ®ndings suggest that SOx may be
responsible at least in part for the structural changes in SBCs.
In conclusion, our results have demonstrated the conspicuous
presence of SOx in the cells of the stratum lucidum and SBCs, in
which dramatic changes in the keratinocytes were seen. Moreover,
the distribution and density of the DACM staining for the S-S
bonds seemed to be altered in accordance with the distribution and
expression of SOx in the epidermis. Taken together, SOx appears
to provide an important biologic function for keratinocytes by
being responsible for the process of structural change in the stratum
lucidum and SBCs via S-S bond formation. It is possible that there
Figure 1. The localization of SOx and S-S formation in differently treated rat newborn skin. Parts (a)±(d) show hematoxilin and eosin
staining; (e)±(h)show immunohistochemical localization of SOx labeled with Cy3 (red) staining in the paraf®n-embedded sections of rat newborn skin
specimens. Nuclear counterstaining was performed using DAPI (blue) staining. Parts (i)±(l)show disul®de bonds by DACM staining in cryo-sections of
rat newborn skin. Samples of dorsal skin from newborn rat were treated with TPA (b, f, j), RA (c, g, k), and UVB irradiation (d, h, l), respectively.
Forty-eight hours after these treatments, the sample specimens were obtained from the dorsum for the subsequent studies. Parts (a), (e) and (i) show
control specimens from untreated dorsal skin. C, corni®ed layer; G; granular layer; thin arrows, apoptotic nuclei in the stratum lucidum; thick arrows,
sunburn cells; arrowheads, level of the stratum lucidum, scale bars: 50 mm.
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are other SOx proteins responsible for S-S that remain undetected
by our antibody. We need further studies to obtain the c-DNA
clone of SOx to detect the other isoforms of the enzyme in the
keratinocyte cDNA library.
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Abundant Expression of Vasoactive Intestinal Polypeptide
Receptor VPAC2 mRNA in Human Skin
To the Editor:
Vasoactive intestinal polypeptide (VIP) is a bioactive peptide that
in¯uences many aspects of cell function and differentiation. The
28-amino acid polypeptide belongs to the glucagon/secretin
superfamily and is widely expressed in the central nervous system
and in peripheral tissues including lung and skin, where it has been
shown to have a multitude of biological functions (Dickinson and
Fleetwood-Walker, 1999). VIP is abundantly present in cutaneous
autonomic and sensory nerve ®bers (Eedy et al, 1994) where it acts
as neuromodulator and participates in the regulation of regional
blood ¯ow. As the expression and localization of VPAC2 mRNA
has not been examined so far, this study was carried out to correlate
VIP and its receptor in the human skin. Surgically resected human
skin samples (n = 24) were obtained from surplus remnants in
excess of that required for pathologic examination after informed
consent.
For mRNA in situ hybridization, VPAC2 receptor cRNA probes
were generated by a standardized protocol using the sequence
corresponding to the region spanning from TM 3±7 of the human
VPAC2 receptor from TSUP1 human T lymphoblast cDNA which
was subcloned into a speci®c vector (pGEM-T vector, Promega,
Madison, WI) (Groneberg et al, 2001a). For antisense probes,
plasmid linearization by restriction with Spe I was followed by
transcription with T7 polymerase, for sense probes, the Nco I
linearized plasmids were transcribed with SP6 polymerase (all
Roche Diagnostics, Mannheim, Germany). The probes were
checked for their integrity by TAE-agarose gel electrophoresis
and ethidium bromide staining.
The VPAC2 receptor mRNA distribution was assessed by
nonisotopic in situ hybridization using a standardized protocol
(Groneberg et al, 2001b) with 6±8 mm cryostat sections of 4%
paraformaldehyde ®xed biopsies.
High resolution interference contrast microscopy revealed
abundant staining in all areas of the biopsies (Fig 1). Positive
VPAC2 mRNA-signals were localized to the cytoplasm of
keratinocytes with a signal intensity that was maximal at the basal
zone and decreasing to super®cial layers (Fig 1A). In the deep part
of the dermis, VPAC2 mRNA hybridization signals were present in
cells of eccrine sweat glands and in cells of the germinative
epithelium, matrix, and medulla of the hair follicle (Fig 1C). Also,
positive VPAC2 mRNA hybridization signals were localized to
endothelial and mononuclear immune cells. Control hybridizations
on alternate sections with equivalent amounts of the digoxigenin
labeled sense-probe using the same hybridization conditions and
washing stringencies were unstained (Fig 1B, D).
To relate the distribution of VPAC2 mRNA to its ligand VIP,
immunohistochemical studies were carried out using mouse
polyclonal (1:1000, Biogenesis, Poole, U.K.) or monoclonal
(1:100 Charles River, Southbridge, MA) VIP-antibodies as
described before (Fischer et al, 1998) with 6±8 mm cryostat
sections and antimouse ¯uorescein-5-isocyanate antiserum (1:400,
Amersham, Braunschweig, Germany) and anti-rabbit biotin (1:200)
± strepatavidin Texas Red (1:400, Amersham) as secondary
antibodies.
Fluorescence microscopy demonstrated an abundant expression
of VIP-immunoreactivity in nerve ®bers which were found as
branching networks surrounding blood vessels, eccrine sweat
glands, and hair follicles (Fig 1E and F) and in direct contact to
VPAC2 mRNA positive cells. Controls by omitting the primary or
secondary antibodies and incubation with the preimmune serum
did not reveal speci®c immunosignals.
VIP binding sites have so far been shown in sweat glands using
unspeci®c binding techniques (Heinz-Erian et al, 1986) and in
allergic contact dermatitis (Lundeberg and Nordlind, 1999). There
is also a large body of evidence on the functional role of VIP as a
possible sensory neuropeptide in normal skin and dermatologic
disorders. VIP protein expression has been demonstrated in normal
skin of young (Eedy et al, 1994) and elderly (Abdel-Rahman et al,
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